J. W. Coons Advisors LLC Decreases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

J. W. Coons Advisors LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,477 shares of the medical equipment provider’s stock after selling 97 shares during the period. J. W. Coons Advisors LLC’s holdings in Intuitive Surgical were worth $771,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the stock. Midwest Capital Advisors LLC purchased a new position in Intuitive Surgical in the 4th quarter worth approximately $54,000. World Equity Group Inc. grew its position in shares of Intuitive Surgical by 22.8% in the 4th quarter. World Equity Group Inc. now owns 512 shares of the medical equipment provider’s stock worth $267,000 after buying an additional 95 shares during the last quarter. MONECO Advisors LLC grew its position in shares of Intuitive Surgical by 8.1% in the 4th quarter. MONECO Advisors LLC now owns 1,129 shares of the medical equipment provider’s stock worth $589,000 after buying an additional 85 shares during the last quarter. Lansing Street Advisors grew its position in shares of Intuitive Surgical by 21.3% in the 4th quarter. Lansing Street Advisors now owns 586 shares of the medical equipment provider’s stock worth $306,000 after buying an additional 103 shares during the last quarter. Finally, Howard Capital Management Inc. grew its position in shares of Intuitive Surgical by 3.5% in the 4th quarter. Howard Capital Management Inc. now owns 10,293 shares of the medical equipment provider’s stock worth $5,373,000 after buying an additional 348 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Down 2.4 %

Intuitive Surgical stock opened at $591.79 on Monday. The business’s fifty day simple moving average is $565.45 and its two-hundred day simple moving average is $525.60. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a market capitalization of $210.78 billion, a price-to-earnings ratio of 92.32, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Piper Sandler reiterated an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Barclays lifted their price objective on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Jefferies Financial Group lifted their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Finally, BTIG Research lifted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.